‹ Back
NEW
ISO 10993-6:2026 vs ISO 10993-6:2016
Biological evaluation of medical devices Part 6: Tests for local effects after implantation
General information
Valid from 04.08.2026
Directives or regulations
none
Handling area
Give feedback
This standard aims to measure tissue reaction, assess local biocompatibility risks, and confirm safe use for medical devices. It is used to describe in detail how tests should be performed for both subcutaneous (under the skin) and intramuscular applications.
The standard is applicable to the below medical devices:
Orthopedic implants (plates, screws, prostheses)
Cardiovascular Devices (Stents, artificial heart valves)
Dental implants
Wound closure Materials (sutures, biomaterials)
Medical Materials with Long-Term contact
Related products
Healthcare, ISO
ISO, Software
ISO 29100:2024 VERSUS ISO 29100:2020
Information technology — Security techniques — Privacy framework.
Healthcare, ISO
ISO 8637-3 2024 Versus ISO 8637-3 2018
Extracorporeal systems for blood purification Part 3: Plasmafilters
Healthcare, IEC
IEC 62083-2026 Vs IEC 62083-2010
Medical device software — Requirements for the safety of radiotherapy treatment planning systems
Healthcare, ISO
ISO 10993-6:2026 vs ISO 10993-6:2016
Price range: $40.00 through $95.00
Biological evaluation of medical devices Part 6: Tests for local effects after implantation